Veracyte



金融业
股票价格
USD
资产
USD 1.37B
现金及等价物
USD 315.57M
销售成本
USD 41.21M
流动资产
USD 449.22M
流动负债
USD 72.15M
债务
USD 50.65M
EBIT
USD 23.11M
EBITDA
USD 39.73M
员工
824
EPS每股收益
USD 0.51
股本和储备
USD 1.26B
销售毛利
USD 91.28M
债务利息支出
USD 2K
利息收入
USD 2.94M
贷款资金
USD 0
市值
USD 2.8B
净收入
USD 19.14M
营业费用
USD 108.76M
营业利润
USD 23.11M
普通股股本
USD 78.67M
PE价格收益
USD 50.7
税前利润
USD 18.89M
销售收入
USD 131.9M
销售和管理费用
USD 51.73M
股票
USD 20.33M
贸易债权人
USD 5.51M
应收帐款人
USD 47.83M


Ebit 更改 日
Agenus USD -13.31M 19.08M 2025-03
Agilent USD 443M 66M 2025-09
Anika Therapeutics USD -4.28M 3.58M 2025-03
Arrowhead Research USD 40.81M 17.01M 2025-12
Bruker USD 76.3M 7.6M 2025-12
Exact Sciences USD -25M 22.85M 2025-09
Heron Therapeutics USD -4.46M 5.76M 2024-09
Illumina USD 256M 6M 2025-12
Intrexon USD -26.3M 2.91M 2024-06
Karyopharm Therapeutics USD -26.28M 1.84M 2024-09
Laboratory Of America USD 382M 11M 2025-12
Ligand Pharmaceuticals USD 158.89M 115.32M 2025-09
Myriad Genetics USD -5.5M 11.1M 2025-03
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Roche Holding CHF 9.56B 2.1B 2025-12
Siemens EUR 2.57B 3M 2025-12
Sonic Healthcare AUD 423.94M 80.3M 2024-12
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Veracyte USD 23.11M 8.8M 2025-09
Waters USD 270.52M 78.4M 2025-12


Veracyte - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.